Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 COVID-19 coagulopathy: is it disseminated intravascular coagulation?

Literature DB >> 33368021

COVID-19 coagulopathy: is it disseminated intravascular coagulation?

Abstract

One of the significant complications of severe COVID-19 infections is a coagulopathy that seems to be related to the occurrence of venous and arterial thromboembolic disease. The coagulation changes mimic but are not identical to disseminated intravascular coagulation (DIC). The vast majority of patients with COVID-19 do not meet the criteria for usual forms of DIC. In addition, there seem to be features of a strong local pulmonary thrombotic microangiopathy and direct endothelial cell infection and injury by the virus that affect the coagulopathic response to severe COVID-19. It seems COVID-19 leads to a distinct intravascular coagulation syndrome that may need separate diagnostic criteria.

Entities: Chemical Disease Gene Species

Keywords: COVID-19; Coagulation; D-dimer; Disseminated intravascular coagulation; Pulmonary embolism; SARS-CoV-2; Thrombosis; Thrombotic microangiopathy

Mesh：

Year: 2020 PMID： 33368021 PMCID： PMC7758412 DOI： 10.1007/s11739-020-02601-y

Source DB: PubMed Journal: Intern Emerg Med ISSN： 1828-0447 Impact factor: 3.397

1 in total

1. Elevated plasma tissue-type plasminogen activator (t-PA) and soluble thrombomodulin in patients suffering from severe acute respiratory syndrome (SARS) as a possible index for prognosis and treatment strategy.

Authors: Zhong-Hua Liu; Ran Wei; Ya-Ping Wu; Ton Lisman; Zeng-Xian Wang; Ji-Ju Han; Dao-Ling Ren; Bin Chen; Zuo-Li Xia; Biao Chen; Zhen Zhu; Yan Zhang; Xing Cui; Hai-Tao Hu; Philip G de Groot; Wen-Bo Xu
Journal: Biomed Environ Sci Date: 2005-08 Impact factor: 3.118

1 in total

25 in total

1. Predictors of venous thromboembolism in COVID-19 patients: results of the COVID-19 Brazilian Registry.

Authors: Warley Cezar da Silveira; Lucas Emanuel Ferreira Ramos; Rafael Tavares Silva; Bruno Barbosa Miranda de Paiva; Polianna Delfino Pereira; Alexandre Vargas Schwarzbold; Andresa Fontoura Garbini; Bruna Schettino Morato Barreira; Bruno Mateus de Castro; Carolina Marques Ramos; Caroline Danubia Gomes; Christiane Corrêa Rodrigues Cimini; Elayne Crestani Pereira; Eliane Würdig Roesch; Emanuele Marianne Souza Kroger; Felipe Ferraz Martins Graça Aranha; Fernando Anschau; Fernando Antonio Botoni; Fernando Graça Aranha; Gabriela Petry Crestani; Giovanna Grunewald Vietta; Gisele Alsina Nader Bastos; Jamille Hemétrio Salles Martins Costa; Jéssica Rayane Corrêa Silva da Fonseca; Karen Brasil Ruschel; Leonardo Seixas de Oliveira; Lílian Santos Pinheiro; Liliane Souto Pacheco; Luciana Borges Segala; Luciana Siuves Ferreira Couto; Luciane Kopittke; Maiara Anschau Floriani; Majlla Magalhães Silva; Marcelo Carneiro; Maria Angélica Pires Ferreira; Maria Auxiliadora Parreiras Martins; Marina Neves Zerbini de Faria; Matheus Carvalho Alves Nogueira; Milton Henriques Guimarães Júnior; Natália da Cunha Severino Sampaio; Neimy Ramos de Oliveira; Nicole de Moraes Pertile; Pedro Guido Soares Andrade; Pedro Ledic Assaf; Reginaldo Aparecido Valacio; Rochele Mosmann Menezes; Saionara Cristina Francisco; Silvana Mangeon Meirelles Guimarães; Silvia Ferreira Araújo; Suely Meireles Rezende; Susany Anastácia Pereira; Tatiana Kurtz; Tatiani Oliveira Fereguetti; Carísi Anne Polanczyk; Magda Carvalho Pires; Marcos André Gonçalves; Milena Soriano Marcolino
Journal: Intern Emerg Med Date: 2022-06-01 Impact factor: 5.472

Review 2. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19.

Authors: Duoduo Zha; Mingui Fu; Yisong Qian
Journal: Cells Date: 2022-06-19 Impact factor: 7.666

3. Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy: Defibrotide as an endothelium-protective, targeted therapy.

Authors: David García-Bernal; Edward Richardson; Israel Vlodavsky; Carmelo Carlo-Stella; Massimo Iacobelli; Rubén Jara; Paul G Richardson; Jose M Moraleda
Journal: EJHaem Date: 2021-06-22

4. Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients.

Authors: Yuichiro Takeshita; Jiro Terada; Yasutaka Hirasawa; Taku Kinoshita; Hiroshi Tajima; Ken Koshikawa; Toru Kinouchi; Yuri Isaka; Yu Shionoya; Atsushi Fujikawa; Yuji Tada; Chiaki Nakaseko; Kenji Tsushima
Journal: J Clin Med Date: 2021-12-27 Impact factor: 4.241

COVID-19 coagulopathy: is it disseminated intravascular coagulation?

1. Elevated plasma tissue-type plasminogen activator (t-PA) and soluble thrombomodulin in patients suffering from severe acute respiratory syndrome (SARS) as a possible index for prognosis and treatment strategy.

1. Predictors of venous thromboembolism in COVID-19 patients: results of the COVID-19 Brazilian Registry.

Review 2. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19.

3. Endothelial dysfunction and its critical role in COVID-19-associated coagulopathy: Defibrotide as an endothelium-protective, targeted therapy.

4. Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients.

5. Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach.

6. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.

Review 7. Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19.

Review 8. Lessons learnt from COVID-19 coagulopathy.

9. Computed tomography features of pulmonary metastases from angiosarcoma: Lessons learned from one case study.

10. Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection.